Literature DB >> 18191357

A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.

A Phani Kumar1, V R L Ganesh, D V Subba Rao, C Anil, B Venugopala Rao, V S Hariharakrishnan, A Suneetha, B Syama Sundar.   

Abstract

An isocratic reversed phase liquid chromatographic (RP-LC) method has been developed and subsequently validated for the determination of almotriptan malate and its process-related impurities. Separation was achieved with a Phenomenex, Gemini, C-18 column and sodium phosphate buffer (pH adjusted to 7.6): acetonitrile (80:20, v/v) as eluent, at a flow rate of 1.5 mL/min. UV detection was performed at 227 nm. The method is simple, rapid, selective, accurate and stability indicating. The described method is linear over a range of LOQ, 1.5 ug/mL (150% of the specification limit) for all the process-related impurities. The method precision for the determination of related compounds was below 1.0% R.S.D. The accuracy of the method demonstrated at 4 levels in the range of 25-150% of the specification limit and the recovery of impurities were found to be in the range of 96-102%. The method is useful in the quality control of bulk manufacturing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18191357     DOI: 10.1016/j.jpba.2007.11.029

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Development and Validation of HPTLC Method for the Estimation of Almotriptan Malate in Tablet Dosage Form.

Authors:  A Suneetha; B Syamasundar
Journal:  Indian J Pharm Sci       Date:  2010-09       Impact factor: 0.975

2.  Two chromatographic methods for the determination of some antimigraine drugs.

Authors:  Ramzia I El-Bagary; Nashwah G Mohammed; Heba A Nasr
Journal:  Anal Chem Insights       Date:  2012-05-14

3.  Method development and validation of almotriptan in human plasma by HPLC tandem mass spectrometry: application to pharmacokinetic study.

Authors:  Konda Ravikumar; Babu Rao Chandu; Balasekhara Reddy Challa; Kottapalli B Chandrasekhar
Journal:  Sci Pharm       Date:  2012-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.